Table 3.
1p/19q FISH | 10q status | 1p/19q PCR microsatellite-based LOH | % FISH-PCR concordance | ||
---|---|---|---|---|---|
codeleted | Intact | ||||
original criteria | codeleted | 10q intact | 52 | 7 | 88.1 |
10q LOH | 4 | 13 | 23.5 | ||
intact | 10q intact | 0 | 13 | 100.0 | |
10q LOH | 1 | 8 | 88.9 | ||
modified criteria | codeleted | 10q intact | 49 | 5 | 90.7 |
10q LOH | 4 | 10 | 28.6 | ||
intact | 10q intact | 3 | 15 | 83.3 | |
10q LOH | 1 | 11 | 91.7 |
Ninety-eight World Health Organization grade II and III oligodendrogliomas were tested for 1p/19q codeletion by FISH and PCR-based LOH analysis and for 10q deletion. Both by original and more stringent modified criteria, if a case was 1p/19q-codeleted and intact for 10q, PCR analysis also called the case codeleted about 90% of the time. If a case was called 1p/19q-codeleted by FISH yet had 10q LOH, PCR analysis called the same tumor negative for codeletion over 70% of the time. If a tumor was 1p/19q intact by either original or modified FISH criteria and also 10q intact, PCR analysis also called it 1p/19q intact 80–100% of the time; the presence of 10q LOH did not appreciably change that proportion (about 90%). FISH = fluorescence in situ hybridization; LOH = loss of heterozygosity; PCR = polymerase chain reaction.